E-ISSN 2231-3206 | ISSN 2320-4672
 

Case Report

Online Publishing Date:
10 / 08 / 2017

 


High-dose cytarabine-associated cerebellar toxicity: A case report

Delcey Reachel Varghese, Dawnwin Joseph, Raghuveer Prabhu, Anila K N.


Abstract
High-dose arabinoside cytarabine is used as an effective regimen for post-remission acute leukemia and refractory leukemia treatment. Most commonly used regimen is 3 g/m2 IV over 1-3 h q12 h for a total of 8-12 doses. Major toxic effects associated with cytarabine are related to bone marrow, gastrointestinal tract, and nervous system. Acute cerebellar toxicity with ataxia and dysarthria is well-known adverse effect during high-dose cytarabine therapy. This case report describes about a patient with acute myeloid leukemia on high-dose cytarabine who developed ataxia and left-sided nystagmus as cerebellar toxicity. These symptoms persisted till 2 days after the termination of high-dose cytarabine the gradually improved with steroids. PatientÂ’s good response to methyl prednisolone illustrates immune-mediated mechanism of neurotoxicity.

Key words: High-dose Arabinoside Cytarabine; Acute Myeloid Leukemia; Neurotoxicity


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Delcey Reachel Varghese
Articles by Dawnwin Joseph
Articles by Raghuveer Prabhu
Articles by Anila K N
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Delcey Reachel Varghese, Dawnwin Joseph, Raghuveer Prabhu, Anila K N. High-dose cytarabine-associated cerebellar toxicity: A case report. Natl J Physiol Pharm Pharmacol. 2018; 8(1): 142-143. doi:10.5455/njppp.2018.8.0724818072017


Web Style

Delcey Reachel Varghese, Dawnwin Joseph, Raghuveer Prabhu, Anila K N. High-dose cytarabine-associated cerebellar toxicity: A case report. https://www.njppp.com/?mno=272003 [Access: March 15, 2024]. doi:10.5455/njppp.2018.8.0724818072017


AMA (American Medical Association) Style

Delcey Reachel Varghese, Dawnwin Joseph, Raghuveer Prabhu, Anila K N. High-dose cytarabine-associated cerebellar toxicity: A case report. Natl J Physiol Pharm Pharmacol. 2018; 8(1): 142-143. doi:10.5455/njppp.2018.8.0724818072017



Vancouver/ICMJE Style

Delcey Reachel Varghese, Dawnwin Joseph, Raghuveer Prabhu, Anila K N. High-dose cytarabine-associated cerebellar toxicity: A case report. Natl J Physiol Pharm Pharmacol. (2018), [cited March 15, 2024]; 8(1): 142-143. doi:10.5455/njppp.2018.8.0724818072017



Harvard Style

Delcey Reachel Varghese, Dawnwin Joseph, Raghuveer Prabhu, Anila K N (2018) High-dose cytarabine-associated cerebellar toxicity: A case report. Natl J Physiol Pharm Pharmacol, 8 (1), 142-143. doi:10.5455/njppp.2018.8.0724818072017



Turabian Style

Delcey Reachel Varghese, Dawnwin Joseph, Raghuveer Prabhu, Anila K N. 2018. High-dose cytarabine-associated cerebellar toxicity: A case report. National Journal of Physiology, Pharmacy and Pharmacology, 8 (1), 142-143. doi:10.5455/njppp.2018.8.0724818072017



Chicago Style

Delcey Reachel Varghese, Dawnwin Joseph, Raghuveer Prabhu, Anila K N. "High-dose cytarabine-associated cerebellar toxicity: A case report." National Journal of Physiology, Pharmacy and Pharmacology 8 (2018), 142-143. doi:10.5455/njppp.2018.8.0724818072017



MLA (The Modern Language Association) Style

Delcey Reachel Varghese, Dawnwin Joseph, Raghuveer Prabhu, Anila K N. "High-dose cytarabine-associated cerebellar toxicity: A case report." National Journal of Physiology, Pharmacy and Pharmacology 8.1 (2018), 142-143. Print. doi:10.5455/njppp.2018.8.0724818072017



APA (American Psychological Association) Style

Delcey Reachel Varghese, Dawnwin Joseph, Raghuveer Prabhu, Anila K N (2018) High-dose cytarabine-associated cerebellar toxicity: A case report. National Journal of Physiology, Pharmacy and Pharmacology, 8 (1), 142-143. doi:10.5455/njppp.2018.8.0724818072017